Canadian Agency for Drugs and Technologies in Health. (2014). Gabapentin for adults with neuropathic pain: A review of the clinical evidence and guidelines. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health.
Chicago Style CitationCanadian Agency for Drugs and Technologies in Health. Gabapentin for Adults With Neuropathic Pain: A Review of the Clinical Evidence and Guidelines. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2014.
MLA CitationCanadian Agency for Drugs and Technologies in Health. Gabapentin for Adults With Neuropathic Pain: A Review of the Clinical Evidence and Guidelines. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2014.
Warning: These citations may not always be 100% accurate.